{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:18:35Z","timestamp":1791389915079,"version":"4.3.3"},"reference-count":81,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.rdc.2014.12.004","type":"journal-article","created":{"date-parts":[[2015,2,2]],"date-time":"2015-02-02T23:46:42Z","timestamp":1422920802000},"page":"225-236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":135,"title":["Lung Disease in Rheumatoid Arthritis"],"prefix":"10.1016","volume":"41","author":[{"given":"Zulma X.","family":"Yunt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua J.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.rdc.2014.12.004_bib1","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1378\/chest.127.6.2019","article-title":"Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease","volume":"127","author":"Lee","year":"2005","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rdc.2014.12.004_bib2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/art.10705","article-title":"Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years","volume":"48","author":"Gabriel","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2014.12.004_bib3","first-page":"62","article-title":"Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis","volume":"29","author":"Turesson","year":"2002","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2014.12.004_bib4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00296-004-0472-y","article-title":"Pulmonary involvement in rheumatoid arthritis","volume":"25","author":"Bilgici","year":"2005","journal-title":"Rheumatol Int"},{"issue":"8","key":"10.1016\/j.rdc.2014.12.004_bib5","first-page":"1513","article-title":"Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis","volume":"35","author":"Mori","year":"2008","journal-title":"J\u00a0Rheumatol"},{"issue":"8","key":"10.1016\/j.rdc.2014.12.004_bib6","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/thx.56.8.622","article-title":"Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests","volume":"56","author":"Dawson","year":"2001","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.rdc.2014.12.004_bib7","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/rheumatology\/kel253","article-title":"Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis","volume":"46","author":"Young","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.rdc.2014.12.004_bib8","first-page":"958","article-title":"National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study","volume":"30","author":"Thomas","year":"2003","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2014.12.004_bib9","first-page":"33","article-title":"Cause of death in 81 autopsied patients with rheumatoid arthritis","volume":"21","author":"Suzuki","year":"1994","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2014.12.004_bib10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/03009740410005845","article-title":"Death rates and causes of death in patients with rheumatoid arthritis: a population-based study","volume":"33","author":"Sihvonen","year":"2004","journal-title":"Scand J Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2014.12.004_bib11","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/rheumatology\/38.7.668","article-title":"Extra-articular rheumatoid arthritis: prevalence and mortality","volume":"38","author":"Turesson","year":"1999","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.rdc.2014.12.004_bib12","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.rdc.2014.12.004_bib13","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.rmed.2012.04.004","article-title":"Rheumatoid lung disease: prognostic analysis of 54 biopsy-proven cases","volume":"106","author":"Nakamura","year":"2012","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.rdc.2014.12.004_bib14","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.00092309","article-title":"Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease","volume":"35","author":"Kim","year":"2010","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.rdc.2014.12.004_bib15","first-page":"21","article-title":"Rheumatoid arthritis-associated interstitial lung disease","author":"Solomon","year":"2012","journal-title":"Open Access Rheumatol Res Rev"},{"issue":"2","key":"10.1016\/j.rdc.2014.12.004_bib16","first-page":"97","article-title":"HLA-B40: a marker for susceptibility to lung disease in rheumatoid arthritis","volume":"9","author":"Charles","year":"1991","journal-title":"Dis Markers"},{"issue":"4","key":"10.1016\/j.rdc.2014.12.004_bib17","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0002-9343(87)90013-1","article-title":"HLA-DR4 and pulmonary dysfunction in rheumatoid arthritis","volume":"82","author":"Scott","year":"1987","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.rdc.2014.12.004_bib18","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/rheumatology\/32.9.794","article-title":"HLA associations in subjects with rheumatoid arthritis and bronchiectasis but not with other pulmonary complications of rheumatoid disease","volume":"32","author":"Hillarby","year":"1993","journal-title":"Br J Rheumatol"},{"issue":"10","key":"10.1016\/j.rdc.2014.12.004_bib19","doi-asserted-by":"crossref","first-page":"612","DOI":"10.2169\/internalmedicine.33.612","article-title":"Diffuse panbronchiolitis and rheumatoid arthritis: a possible correlation with HLA-B54","volume":"33","author":"Sugiyama","year":"1994","journal-title":"Intern Med"},{"issue":"2","key":"10.1016\/j.rdc.2014.12.004_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/archinternmed.2007.59","article-title":"Progressive preclinical interstitial lung disease in rheumatoid arthritis","volume":"168","author":"Gochuico","year":"2008","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.rdc.2014.12.004_bib21","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1053\/sarh.2001.27719","article-title":"Cigarette smoking and rheumatoid arthritis","volume":"31","author":"Albano","year":"2001","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2014.12.004_bib22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/BOR.0000000000000017","article-title":"When and where does inflammation begin in rheumatoid arthritis?","volume":"26","author":"Demoruelle","year":"2014","journal-title":"Curr Opin Rheumatol"},{"issue":"10","key":"10.1016\/j.rdc.2014.12.004_bib23","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/ard.2007.075192","article-title":"Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells","volume":"67","author":"Makrygiannakis","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.rdc.2014.12.004_bib24","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1002\/art.38066","article-title":"Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease","volume":"65","author":"Willis","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2014.12.004_bib25","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/art.37881","article-title":"Identification of citrullinated hsp90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease","volume":"65","author":"Harlow","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.rdc.2014.12.004_bib26","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/annrheumdis-2012-203160","article-title":"Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease","volume":"73","author":"Giles","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.rdc.2014.12.004_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/art.38904","article-title":"Biomarkers of rheumatoid arthritis-associated interstitial lung disease","volume":"67","author":"Chen","year":"2015","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2014.12.004_bib28","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1164\/rccm.201004-0622OC","article-title":"Rheumatoid arthritis-interstitial lung disease-associated mortality","volume":"183","author":"Olson","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.rdc.2014.12.004_bib29","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.rdc.2014.12.004_bib30","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.rmed.2013.05.002","article-title":"Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD)","volume":"107","author":"Solomon","year":"2013","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.rdc.2014.12.004_bib31","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/resp.12234","article-title":"Predictors of mortality in rheumatoid arthritis-related interstitial lung disease","volume":"19","author":"Assayag","year":"2014","journal-title":"Respirology"},{"issue":"7","key":"10.1016\/j.rdc.2014.12.004_bib32","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1164\/rccm.200607-912OC","article-title":"Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes","volume":"175","author":"Park","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"5 Pt 1","key":"10.1016\/j.rdc.2014.12.004_bib33","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1164\/ajrccm.157.5.9710018","article-title":"Airways involvement in rheumatoid arthritis: clinical, functional, and HRCT findings","volume":"157","author":"Perez","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.rdc.2014.12.004_bib34","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3899\/jrheum.121043","article-title":"Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease","volume":"40","author":"Fischer","year":"2013","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2014.12.004_bib35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0012-3692(15)50949-5","article-title":"Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease","volume":"130","author":"Swigris","year":"2006","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.rdc.2014.12.004_bib36","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/resp.12214","article-title":"Rituximab in severe, treatment-refractory interstitial lung disease","volume":"19","author":"Keir","year":"2014","journal-title":"Respirology"},{"issue":"6","key":"10.1016\/j.rdc.2014.12.004_bib37","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s00296-012-2587-x","article-title":"Rituximab: rescue therapy in life-threatening complications or refractory autoimmune diseases: a single center experience","volume":"33","author":"Braun-Moscovici","year":"2013","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.rdc.2014.12.004_bib38","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3346\/jkms.2002.17.2.270","article-title":"Successful treatment of progressive rheumatoid interstitial lung disease with cyclosporine: a case report","volume":"17","author":"Chang","year":"2002","journal-title":"J\u00a0Korean Med Sci"},{"issue":"11","key":"10.1016\/j.rdc.2014.12.004_bib39","first-page":"2163","article-title":"Treatment of progressive rheumatoid interstitial lung disease with cyclosporine","volume":"22","author":"Puttick","year":"1995","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2014.12.004_bib40","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1183\/09031936.04.00076904","article-title":"Infliximab treatment in a patient with rheumatoid arthritis and pulmonary fibrosis","volume":"24","author":"Bargagli","year":"2004","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.rdc.2014.12.004_bib41","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.122.3.1093","article-title":"Clinical response of rheumatoid arthritis-associated pulmonary fibrosis to tumor necrosis factor-alpha inhibition","volume":"122","author":"Vassallo","year":"2002","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.rdc.2014.12.004_bib42","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/rheumatology\/kel090","article-title":"Acute progression of interstitial lung disease: a complication of etanercept particularly in the presence of rheumatoid lung and methotrexate treatment","volume":"45","author":"Lindsay","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"7477","key":"10.1016\/j.rdc.2014.12.004_bib43","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1136\/bmj.329.7477.1266","article-title":"Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab","volume":"329","author":"Ostor","year":"2004","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.rdc.2014.12.004_bib44","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/ard.2009.120626","article-title":"Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register","volume":"69","author":"Dixon","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.rdc.2014.12.004_bib45","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.healun.2014.01.858","article-title":"Survival and quality of life in rheumatoid arthritis-associated interstitial lung disease after lung transplantation","volume":"33","author":"Yazdani","year":"2014","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"3","key":"10.1016\/j.rdc.2014.12.004_bib46","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.38.3.222","article-title":"Airways obstruction in rheumatoid arthritis","volume":"38","author":"Geddes","year":"1979","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.rdc.2014.12.004_bib47","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/art.1780190316","article-title":"Obstructive pulmonary disease in rheumatoid arthritis","volume":"19","author":"Collins","year":"1976","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.rdc.2014.12.004_bib48","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/ard.53.8.511","article-title":"Bronchial reactivity and airflow obstruction in rheumatoid arthritis","volume":"53","author":"Hassan","year":"1994","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.rdc.2014.12.004_bib49","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1148\/radiology.158.2.3941873","article-title":"Cricoarytenoiditis: CT assessment in rheumatoid arthritis","volume":"158","author":"Brazeau-Lamontagne","year":"1986","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.rdc.2014.12.004_bib50","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/03009740701393957","article-title":"Pulmonary involvement in patients with early rheumatoid arthritis","volume":"36","author":"Metafratzi","year":"2007","journal-title":"Scand J Rheumatol"},{"issue":"10","key":"10.1016\/j.rdc.2014.12.004_bib51","first-page":"768","article-title":"Bronchiectasis in rheumatoid arthritis. High resolution computed pulmonary tomography","volume":"81","author":"Kochbati","year":"2003","journal-title":"Tunis Med"},{"key":"10.1016\/j.rdc.2014.12.004_bib52","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/1471-2334-11-304","article-title":"Risk of infections in bronchiectasis during disease-modifying treatment and biologics for rheumatic diseases","volume":"11","author":"Geri","year":"2011","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.rdc.2014.12.004_bib53","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2214\/ajr.185.2.01850354","article-title":"Radiologic and pathologic features of bronchiolitis","volume":"185","author":"Pipavath","year":"2005","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.rdc.2014.12.004_bib54","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.rmed.2013.02.019","article-title":"FEV1 over time in patients with connective tissue disease-related bronchiolitis","volume":"107","author":"Fernandez Perez","year":"2013","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.rdc.2014.12.004_bib55","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1183\/09031936.00091608","article-title":"Characterisation of severe obliterative bronchiolitis in rheumatoid arthritis","volume":"33","author":"Devouassoux","year":"2009","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.rdc.2014.12.004_bib56","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0049-0172(95)80034-4","article-title":"Pulmonary involvement in rheumatoid arthritis","volume":"24","author":"Anaya","year":"1995","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.rdc.2014.12.004_bib57","doi-asserted-by":"crossref","first-page":"648","DOI":"10.5694\/j.1326-5377.1986.tb112350.x","article-title":"Pleuropulmonary necrobiotic rheumatoid nodules. A review and clinicopathological study of six patients","volume":"144","author":"Walters","year":"1986","journal-title":"Med J Aust"},{"issue":"4","key":"10.1016\/j.rdc.2014.12.004_bib58","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1378\/chest.93.4.876","article-title":"Pulmonary hypertension in a patient with rheumatoid arthritis","volume":"93","author":"Morikawa","year":"1988","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.rdc.2014.12.004_bib59","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/ard.62.5.407","article-title":"Diagnostic strategy for the assessment of rheumatoid vasculitis","volume":"62","author":"Voskuyl","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.rdc.2014.12.004_bib60","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00296-007-0322-9","article-title":"Pleural effusion associated with rheumatoid arthritis: what cell predominance to anticipate?","volume":"27","author":"Avnon","year":"2007","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.rdc.2014.12.004_bib61","first-page":"465","article-title":"The pathognomonic cytologic picture of rheumatoid pleuritis. The 1989 Maurice Goldblatt Cytology award lecture","volume":"34","author":"Naylor","year":"1990","journal-title":"Acta Cytol"},{"issue":"10","key":"10.1016\/j.rdc.2014.12.004_bib62","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/art.1780401016","article-title":"Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review","volume":"40","author":"Kremer","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"6091","key":"10.1016\/j.rdc.2014.12.004_bib63","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/bmj.2.6091.867","article-title":"Pleurisy and methotrexate treatment","volume":"2","author":"Walden","year":"1977","journal-title":"Br Med J"},{"issue":"10","key":"10.1016\/j.rdc.2014.12.004_bib64","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/art.1780261015","article-title":"Acute lung disease associated with low-dose pulse methotrexate therapy in patients with rheumatoid arthritis","volume":"26","author":"Cannon","year":"1983","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.rdc.2014.12.004_bib65","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/archinte.1985.00360110105023","article-title":"Pneumonitis complicating low-dose methotrexate therapy in rheumatoid arthritis","volume":"145","author":"St Clair","year":"1985","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.rdc.2014.12.004_bib66","first-page":"74","article-title":"Toxicity of methotrexate in rheumatoid arthritis","volume":"14","author":"Gispen","year":"1987","journal-title":"J\u00a0Rheumatol"},{"issue":"1 Pt 2","key":"10.1016\/j.rdc.2014.12.004_bib67","first-page":"e31","article-title":"The lung in rheumatoid arthritis","volume":"40","author":"Amital","year":"2011","journal-title":"Presse Med"},{"issue":"7","key":"10.1016\/j.rdc.2014.12.004_bib68","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/ard.53.7.434","article-title":"Methotrexate-related pulmonary complications in rheumatoid arthritis","volume":"53","author":"Barrera","year":"1994","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.rdc.2014.12.004_bib69","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.3899\/jrheum.090030","article-title":"Pulmonary nodulosis and aseptic granulomatous lung disease occurring in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha-blocking agent: a case series","volume":"36","author":"Toussirot","year":"2009","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2014.12.004_bib70","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1378\/chest.122.5.1858","article-title":"Lung injury linked to etanercept therapy","volume":"122","author":"Peno-Green","year":"2002","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.rdc.2014.12.004_bib71","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s10067-009-1169-0","article-title":"Bronchospasm associated with anti-TNF treatment","volume":"28","author":"Dubey","year":"2009","journal-title":"Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2014.12.004_bib72","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1586\/1744666X.2013.811173","article-title":"Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis","volume":"9","author":"Atzeni","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"issue":"5","key":"10.1016\/j.rdc.2014.12.004_bib73","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.semarthrit.2013.09.005","article-title":"Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review","volume":"43","author":"Roubille","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2014.12.004_bib74","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/s10165-005-0387-9","article-title":"Leflunomide-related lung injury in patients with rheumatoid arthritis: imaging features","volume":"15","author":"Sakai","year":"2005","journal-title":"Mod Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2014.12.004_bib75","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/art.21806","article-title":"Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis","volume":"54","author":"Suissa","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2014.12.004_bib76","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1183\/09031936.00080209","article-title":"Rituximab-induced lung disease: a systematic literature review","volume":"35","author":"Liote","year":"2010","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.rdc.2014.12.004_bib77","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1183\/09031936.02.00267402","article-title":"Sulphasalazine and lung toxicity","volume":"19","author":"Parry","year":"2002","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.rdc.2014.12.004_bib78","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1378\/chest.101.4.1033","article-title":"Sulfasalazine-induced pulmonary disease","volume":"101","author":"Hamadeh","year":"1992","journal-title":"Chest"},{"issue":"19","key":"10.1016\/j.rdc.2014.12.004_bib79","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.2169\/internalmedicine.50.5497","article-title":"A\u00a0case of organizing pneumonia induced by tocilizumab","volume":"50","author":"Ikegawa","year":"2011","journal-title":"Intern Med"},{"issue":"12","key":"10.1016\/j.rdc.2014.12.004_bib80","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1007\/s00296-010-1525-z","article-title":"A\u00a0fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab","volume":"32","author":"Kawashiri","year":"2012","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.rdc.2014.12.004_bib81","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/art.20303","article-title":"Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial","volume":"50","author":"Nishimoto","year":"2004","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X14001252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X14001252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:14:45Z","timestamp":1760181285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X14001252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0889857X14001252"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2014.12.004","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lung Disease in Rheumatoid Arthritis","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2014.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}